chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mildly diffused viral exanthem; mildly itchy rash from neck to thighs; This spontaneous case was reported by a physician and describes the occurrence of VIRAL RASH (mildly diffused viral exanthem) and RASH PRURITIC (mildly itchy rash from neck to thighs) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065K21A, 048C21A and 023M20A) for COVID-19 vaccination.     The patient had never been diagnosed with/ tested positive for COVID-19.  Concurrent medical conditions included Blood pressure abnormal and Environmental allergy.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2022, the patient experienced VIRAL RASH (mildly diffused viral exanthem) and RASH PRURITIC (mildly itchy rash from neck to thighs). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) for Rash, at an unspecified dose and frequency. At the time of the report, VIRAL RASH (mildly diffused viral exanthem) and RASH PRURITIC (mildly itchy rash from neck to thighs) was resolving.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included unspecified drug for blood pressure. It was reported that, 48 hours after the 2nd booster dose she experienced mildly diffused viral exanthem which she depicted as mildly itchy rash from neck to thighs. She still had it, but it was resolving.   This case was linked to MOD-2022-540077, MOD-2022-540074 (Patient Link).   Reporter did not allow further contact
I am 27 weeks pregnant when I got the TDAP vaccine.  The following day at work in early afternoon I started feeling lightheaded, fatigued, and I felt as I was going to vomit. I needed to take it easy for the rest of the day and even the next day I felt still slightly fatigued, slightly lightheaded when I was walking around at work and moments during the day I felt I was going to throw up and I knew I needed to take it easy, sit down and try to relax.
A few days after getting varicella and Tdap vaccine, she noticed itching in different places of her body and when she scratched, would get hives.  Then, on 3/4 she woke up with pain in her left middle finger MCP joint could not bend it.  The pain migrated then to different joints in right thumb, wrist, and then in her knees.  Has been moving around.
Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose; Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose; Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose; Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose), HEADACHE (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose), MYALGIA (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose) and PYREXIA (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HYPERHIDROSIS (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose), HEADACHE (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose), MYALGIA (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose) and PYREXIA (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose). At the time of the report, HYPERHIDROSIS (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose), HEADACHE (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose), MYALGIA (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose) and PYREXIA (Patient got Fever~104,headache,bodyaches, and sweat 12 hours after receiving 1st dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Body temperature: 104 High. On 24-Feb-2021, SARS-CoV-2 test: positive positive covid  positive around sometime in November..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided.  No relevant concomitant medications were reported. Treatment details included Tylenol.   Reporter did not allow further contact
Patient's reported that side of her back has been hurting since day 1; Patient's arm was sore since day 1 after receiving 2nd dose; Patient's arm was red since day 1; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Patient's reported that side of her back has been hurting since day 1), VACCINATION SITE PAIN (Patient's arm was sore since day 1 after receiving 2nd dose) and VACCINATION SITE ERYTHEMA (Patient's arm was red since day 1) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 16-Mar-2021, the patient experienced BACK PAIN (Patient's reported that side of her back has been hurting since day 1), VACCINATION SITE PAIN (Patient's arm was sore since day 1 after receiving 2nd dose) and VACCINATION SITE ERYTHEMA (Patient's arm was red since day 1). At the time of the report, BACK PAIN (Patient's reported that side of her back has been hurting since day 1) was resolving and VACCINATION SITE PAIN (Patient's arm was sore since day 1 after receiving 2nd dose) and VACCINATION SITE ERYTHEMA (Patient's arm was red since day 1) outcome was unknown.            Concomitant medication history not provided.   Treatment information was unknown.  Additional information was received on 11-May-2021, event outcome was updated for Back pain, no and the patient denied further contact.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow-up received event outcome for event back pain updated.
.On 2/27/2019 at 2 pm. At 8pm severe stomachache/cramping she was running a fever of 101 degrees and became nauseous with vomiting and diarrhea from 1030pm to midnight. Joint soreness all over and low fever continued all day 2-28-2019. On 3-1-2019 slight swelling near her collarbone and joint soreness and nausea. 3-2-2019 soreness and then 3-3-2019 back to normal.
Approximate 5 inch red area to left arm around injection site. No itching or pain noted. No swelling. Ice to area. Tylenol for discomfort
heart rate spiked; difficult to catch breath; This is a spontaneous report from a contactable healthcare professional. A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EK5730), via an unspecified route of administration in the right arm, on 18Dec2020 (at the age of 39-years-old) at a single dose for COVID-19 immunization. Medical history included Hashimoto's thyroiditis, depression, acid reflux, and COVID-19 (prior to vaccination). The patient has no known allergies. The patient was not pregnant at the time of vaccination. Concomitant medications, within two weeks prior to vaccination, included sertraline (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), liothyronine sodium (T3), and levothyroxine sodium (T4). The patient experienced heart rate spiked and difficult to catch breath on 20Dec2020. The events were reported as non-serious. The clinical course was reported as follows: In Dec2020, the heart rate spiked to 194 when running outside and it was difficult to catch breath, so the patient ran/walked the 3 mile route. The heart rate spiked to 183 during a strength training workout and to 148 during a low impact weight training, which is unusual for the patient (as reported). The patient did not receive any treatment for the events. The clinical outcome of heart rate spiked and difficult to catch breath was recovered in Dec2020. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Cramping has moved to his lower leg; Leg pain moved to lower leg; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Cramping has moved to his lower leg) and PAIN IN EXTREMITY (Leg pain moved to lower leg) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Cramping has moved to his lower leg) and PAIN IN EXTREMITY (Leg pain moved to lower leg). At the time of the report, MUSCLE SPASMS (Cramping has moved to his lower leg) and PAIN IN EXTREMITY (Leg pain moved to lower leg) outcome was unknown.            Concomitant information was not provided.   The reporter did not know when patient received his first shots. She thought it he received both in February.  Treatment information was not provided.
After 10 minutes of observation time, the patient developed difficulty breathing and swelling of the neck and tongue.  50 mg of Diphenhydramine was given by mouth.  There was no change after 30 minutes post-Diphenhydramine.  Online medical control was contacted.  Dr. suggested the patient be transported to the hospital via ambulance.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE
Pt with Red, hot injection site. Polyuria, Diarrhea, Myalgia, Low Grade Fever (99.9) Nausea, Facial swelling
5mins post vaccination pt reported nausea and dizziness.  Pt had a syncopal episode. Vitals: 09:07 95/52 -- > 09:20 105/52, 76, 15. Pt reports that she did not each before vaccination.  Pt counseled on eating prior to next dose.  Pt stable and released from the vaccination site.
Headache. Fever, NauseaVomiting,  Bell's Palsy-L sided Employee reports burning sensation down L arm around 7:00pm following vaccination. She admits HA, nausea, vomiting and fever of 101 shortly after that. Employee reports she woke up yesterday and noticed L sided facial drooping. She presented to a local ED for evaluation after speaking with her PCP. She was diagnosed with Bells' Palsy and is currently undergoing treatment.
At around 1 pm on 1/5/2021, my right face started feeling weird. There was a tightness/tingling sensation starting below the right eye down to my whole cheek. This reaction was present until the following day, 1/6/21 and seemed to resolve on the morning of 1/7/21
Patient's arm got red and swelled and was warm. By the time they came in had gone down.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 9:06 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 9:06 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 28.53 years.  Concomitant products were not provided.  On 06-Apr-2021, the vaccine with batch number 044B21A was moved to fridge. On 15-Apr-2021, 18 vials were moved to the clinic. On 15-Apr-2021 at 9 AM, vials underwent temperature excursion with temperature of 34 degrees Fahrenheit. The condition of vaccine prior to vaccination was not frozen. The vaccine beyond use date was reported as 09-May-2021.  It was reported that, the storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a traceable temperature monitor at every hour.  It was reported that, the patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021. The health care professional explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree Fahrenheit.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Adverse event included loss of color in face (patient turned pale) including lips, eye rolled upward staring at ceiling, patient slouching on bench until flat on back on bench (head in mother's arms); patient remained like this for at least a couple minutes while mother was yelling for help; patient eventually regained focus and comforted mother in return; patient reported could not see well and experienced dizziness and still had complete loss of color in face; epinephrine pen was not used on patient--only cold wet compress (paper towel) and some air from fan; 911 was called during the incident and paramedics took 10-15 minutes to arrive on scene; mother hysterically crying while pharmacist and manager remained with patient until paramedics brought patient on stretcher to a local hospital
Redness and swelling of injection site of ADACEL. Allergic reaction - Prednisone 10mg 1 daily for 5 days.
Minor body aches for first 3 days. Took Tylenol to relieve the discomfort. On day 4, woke up with severe lower back pain. Took Advil throughout the day and tried to ease the pain by applying heat, doing stretches and walking. Got some relief. On day 5, severe lower back pain again, but now mostly on left side. Applying heat, took 4 Advil, and starting to feel a little relief, but far from gone. I have not contacted my doctor at this point, but if this pain does not subside within the next 24 hours, I will be doing so.
He got his vaccine, he had the fever that evening. Overnight he started vomiting some brown gunk that looked like dried up blood from 1:00-2:00 AM. He did not have much of an appetite. This continued the following night around the same time.  Then he started vomiting again the third day after the vaccine, and he vomited after work and was pretty much vomiting nonstop and started having difficulty in swallowing. Feeling fatigued. On Thursday morning at 2:00 AM he went to the ER on 4/29/21 and they prescribed him some anti-vomiting medication. That worked for about a day. On Friday he started spitting into a cup and spit about 3-5 cups of spit. On Saturday he went to the hospital on 5/1/21 and looked in his throat and said that he had some acidic burns from the vomiting and prescribed him Ondansetron 4 mg for the vomiting, which he did not take much of. They also prescribed him Diphenhydramine elixir to soothe his throat which he took every 6 hours which worked like wonders he said. He started to feel better after that point. He tested negative for COVID in the negative. He did have COVID in November of 2020, and he had vomiting at that time as well.  He was sick with COVID for about a week. He did not have much of an appetite either. He also felt very fatigued and felt better following Thanksgiving and tested negative the Monday after Thanksgiving. The fatigue symptoms lasted about 3 weeks after he tested negative, so he was sick for about a month in total.
The pt was given subcutaneously. Approximately 2-3 minutes later the pt showed signs of an adverse reaction, a large welt with warmness and redness occurred. Parents were instructed by there MD to apply cool compresses and administer Tylenol.
Woke up 2 days after getting Influenza Vaccine with Right Forearm, Wrist, Flank-Rib area, Calf, Foot and Ankle Pain, muscle stiffness and tightness. Patient was seen at 10:55 on 8 Nov 2010 with the following Temp: 98.2, Pulse:80, BP:128/80. Treated with non-steroidal anti inflammatory drugs (NSAIDS); Ibuprofen 800mg and Cyclobenzaprine 10mg 1 tablet every 8 hours as needed for muscle pain.
Client stated he felt dizzy and faint after vaccine was administered. Vital signs were initiated, legs were elevated and cold compress was place on the back of the clients neck. Within 10Minutes client stated he felt better , drank some water.
severe headache, vomiting, fever 102.8. Sent to ER for assessment.
recently diagnosed Leukemia; This spontaneous case was reported by a consumer and describes the occurrence of LEUKAEMIA (recently diagnosed Leukemia) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced LEUKAEMIA (recently diagnosed Leukemia) (seriousness criterion medically significant). At the time of the report, LEUKAEMIA (recently diagnosed Leukemia) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medication and treatment details were not provided.  Company comment: This case concerns a female patient (age not provided) with no relevant medical history, who experienced the unexpected serious event of Leukemia. The event occurred at an unspecified interval after an unknown dose of mRNA-1273 (Moderna covid-19). Limited information provided preludes a complete medical and causal assessment of this case. The benefit-risk relationship of mRNA-1273 (Moderna covid-19 vaccine) is not affected by this report.; Sender's Comments: This case concerns a female patient (age not provided) with no relevant medical history, who experienced the unexpected serious event of Leukemia. The event occurred at an unspecified interval after an unknown dose of mRNA-1273 (Moderna covid-19). Limited information provided preludes a complete medical and causal assessment of this case. The benefit-risk relationship of mRNA-1273 (Moderna covid-19 vaccine) is not affected by this report.
contract Covid after vaccination; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (contract Covid after vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Nov-2021, the patient experienced COVID-19 (contract Covid after vaccination). At the time of the report, COVID-19 (contract Covid after vaccination) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported Patient was asking if they can get a booster dose of vaccine as they had contracted COVID-19 earlier.  Company comment: This is a spontaneous case concerning a patient of unknown age and gender, with no reported medical history, who experienced the non-serious unexpected, according RA, AESI of COVID-19. The event occurred approximately 7 months after the second dose of mRNA-1273 vaccine, exact date of vaccination not provided. The outcome of the event was not reported. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a patient of unknown age and gender, with no reported medical history, who experienced the non-serious unexpected, according RA, AESI of COVID-19. The event occurred approximately 7 months after the second dose of mRNA-1273 vaccine, exact date of vaccination not provided. The outcome of the event was not reported. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
8 days post vaccine, 01/07/2022, it started all over again, exactly like  the 2nd dose of the Moderna ( VAERS reported summited),the hives/rash were in my ears, groin, everywhere, worse than the 2nd dose. It was itchy red, burning. I It was horrible.  01/08/2021, I called my doctor, she immediately prescribed  prednisone on that day,  I started with Prednisone 60 mg,  drop down and tapered down to 0 mg and I still have the rash  till this day, 01/31/2022.   I still have the hives. I am completely exhausted. I cannot sleep.  I am up scratching, it 's horrible. I have missed work.
Headache & Myalgia Narrative:  CHILLS MYALGIAS AND HEADACHE REPORTED
Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Systemic: Seizure-Severe, Additional Details: Difficulty seeing clearly. Difficulty hearing.
Left deltoid red, swollen, warm and tender to touch, firm, painful.  Measures 7 cm x 5.5 cm.